Hyojin Ko Selected Research

1-piperidinylimidazole

1/2016

Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyojin Ko Research Topics

Disease

6	Neoplasms (Cancer) 11/2016 - 04/2011
3	Pain (Aches) 01/2017 - 01/2013
1	Glioblastoma (Glioblastoma Multiforme) 05/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Neuralgia (Stump Neuralgia) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Myocarditis (Carditis) 09/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Triple Negative Breast Neoplasms 01/2016
1	Mouth Neoplasms (Oral Cancer) 04/2015
1	Arthritis (Polyarthritis) 03/2015
1	Edema (Dropsy) 03/2015
1	Squamous Cell Carcinoma of Head and Neck 02/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2011
1	Glioma (Gliomas) 12/2009
1	Astrocytoma (Pilocytic Astrocytoma) 03/2007
1	Colonic Neoplasms (Colon Cancer) 04/2003

Drug/Important Bio-Agent (IBA)

3	Photosensitizing Agents (Photosensitizers)IBA 04/2015 - 09/2011
3	pheophorbide aIBA 04/2015 - 09/2011
2	Purinergic P2X7 ReceptorsIBA 05/2018 - 01/2016
1	quinolineIBA 05/2018
1	QuinolonesIBA 05/2018
1	Purinergic P2X3 ReceptorsIBA 01/2017
1	ProdrugsIBA 01/2017
1	EstersIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 11/2016
1	Peptide Hydrolases (Proteases)FDA Link 09/2016
1	1-piperidinylimidazoleIBA 01/2016
1	imidazoleIBA 01/2016
1	UracilIBA 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2015
1	cyclic (arginyl- glycyl- aspartyl- phenylalanyl- lysyl)IBA 04/2015
1	Peptides (Polypeptides)IBA 04/2015
1	Leuprolide (Lupron)FDA LinkGeneric 04/2015
1	Collagen Type II (Type II Collagen)IBA 03/2015
1	CarrageenanIBA 03/2015
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Pregabalin (Lyrica)FDA Link 01/2013
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 01/2013
1	ChlorineIBA 09/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2011
1	NAD (NADH)IBA 04/2011
1	EnzymesIBA 04/2011
1	NitrogenIBA 04/2011
1	Poly I-CIBA 04/2011
1	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2011
1	PyrrolesIBA 04/2011
1	Nicotinamide PhosphoribosyltransferaseIBA 04/2011
1	InterferonsIBA 04/2011
1	Uridine Diphosphate (UDP)IBA 12/2009
1	Cyclic AMP (AMP, Cyclic)IBA 12/2009
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 12/2009
1	NucleotidesIBA 03/2007
1	ResveratrolIBA 04/2003

Therapy/Procedure

2	Photochemotherapy (Photodynamic Therapy) 04/2015 - 02/2015
2	Therapeutics 04/2015 - 09/2011
1	Intravenous Injections 01/2017
1	Ligation 01/2017
1	Drug Therapy (Chemotherapy) 01/2017